Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by consultant99on Sep 14, 2019 10:33pm
227 Views
Post# 30127811

RE:RE:RE:RE:Warrants

RE:RE:RE:RE:WarrantsThe warrant price is made up of time value and intrinsic value. Currently the stock price is below the strike price so it has 0 value. Therefore the time value is 0.16 

My point is is that if the warrants trade like stock options time value usually doesn’t rise as fast as the stock price particularly when the warrants get above 0.35 and there is intrinsic value. So I would expect at some point the spread between the share and warrant price will bottom out  (currently 0.08) and thereafter start increasing as the share rises. 

Another thing to consider is whether warrants can be shorted. If yes it would be possible to create a synthetic warrant by buying the stock at (0.24) and selling a warrant short for +0.16
The net effect of this would be owning the stock for a net cost of 0.08 and having an obligation 5 years from now to deliver the shares for 0.35 - a nice return of 337% if the warrants are exercised as expected. The higher the warrant price relative to the share price the more attractive this strategy.

We live in interesting times...
Bullboard Posts